AKOYA BIOSCIENCES INC

Akoya to Participate at Two Upcoming Investor Conferences

27 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

12 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

28 Jun 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting

01 Jun 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance

05 May 2022 15:05:03 By Nasdaq GlobeNewswire

Akoya to Participate at Three Upcoming Investor Conferences

03 May 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer

19 Apr 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya to Report First Quarter 2022 Financial Results on May 5th, 2022

14 Apr 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Showcase New Data on PhenoCycler-Fusion at the AACR Annual Meeting 2022

06 Apr 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Reports Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook

14 Mar 2022 15:05:00 By Nasdaq GlobeNewswire

Akoya to Report Fourth Quarter and Full Year 2021 Financial Results on March 14th, 2022 and Present at the Cowen Annual Health Care Conference on March 8th, 2022

22 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

Akoya Biosciences to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

03 Feb 2022 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Appoints Marilee Moy as Chief People Officer

20 Jan 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System

13 Jan 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021

10 Jan 2022 07:00:01 By Nasdaq GlobeNewswire

Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution

05 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

Akoya Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event

15 Dec 2021 11:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers

13 Dec 2021 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Secures CLIA Lab Certification, a Milestone for Applying Its Spatial Biology Technologies to Accelerating Precision Cancer Therapies

30 Nov 2021 07:05:00 By Nasdaq GlobeNewswire